Inhibition of mTOR by rapamycin does not improve hypoxic pulmonary hypertension-induced right heart failure in old mice

Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin attenuates heart failure (HF) and age-associated changes in left ventricular (LV) function. Rapamycin has also been suggested as a therapy for pulmonary hypertension (PH) and concomitant right heart failure (PH-RHF) based on reports...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Exp Gerontol
Main Authors: McNair, Benjamin D., Schlatter, Jacob A., Cook, Ross F., Yusifova, Musharraf, Bruns, Danielle R.
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248895/
https://ncbi.nlm.nih.gov/pubmed/33971279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exger.2021.111395
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares